Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Part B/Part D Drug Coverage Shifts Should Await 2008, CMS Tells Congress

Executive Summary

The Centers for Medicare & Medicaid Services believes switching drug coverage for a small number of products from Part B to Part D is worth considering, but not until the outpatient drug benefit has been underway for at least two years

You may also be interested in...



Biologics Under Part D: Coinsurance, Cost Containment And Coverage Overlap

Coinsurance appears to be the preferred cost-sharing method for biologics in Medicare Part D plans, according to an analysis of plan formularies by "The Pink Sheet."

Biologics Under Part D: Coinsurance, Cost Containment And Coverage Overlap

Coinsurance appears to be the preferred cost-sharing method for biologics in Medicare Part D plans, according to an analysis of plan formularies by "The Pink Sheet."

Medicare Rx Requires Pharmacies To Mind Their B’s And D’s

Pharmacists will have to keep careful track of prescriptions for some medicines that can be covered by Medicare Part B once the new Part D outpatient drug benefit begins in 2006

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045680

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel